Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.

Schwarz UI, Stein CM
Clin Pharmacol Ther. 2006 80 (1): 7-12

PMID: 16815312 · DOI:10.1016/j.clpt.2006.04.008

MeSH Terms (10)

Acenocoumarol Administration, Oral Anticoagulants Aryl Hydrocarbon Hydroxylases Cytochrome P-450 CYP2C9 Genotype Humans Mixed Function Oxygenases Vitamin K Epoxide Reductases Warfarin

Connections (1)

This publication is referenced by other Labnodes entities: